Loading...
XLONAMS
Market cap535mUSD
Dec 24, Last price  
199.40GBP
1D
1.42%
1Q
-9.36%
Jan 2017
-10.08%
Name

Advanced Medical Solutions Group PLC

Chart & Performance

D1W1MN
XLON:AMS chart
P/E
2,690.07
P/S
338.66
EPS
0.07
Div Yield, %
0.01%
Shrs. gr., 5y
0.30%
Rev. gr., 5y
4.23%
Revenues
126m
+1.51%
11,019,00012,892,00014,322,00016,856,00020,316,00024,091,00031,881,00034,353,00052,589,00059,499,00063,010,00068,596,00083,242,00096,908,000102,598,000102,368,00086,796,000108,601,000124,330,000126,210,000
Net income
16m
-22.14%
-417,000276,000747,0002,236,0003,309,0002,784,0004,833,0004,850,0009,692,00011,366,00012,864,00014,119,00015,692,00020,134,00022,650,00018,919,0008,584,00017,481,00020,406,00015,889,000
CFO
12m
-54.41%
-239,000691,0001,479,0003,671,0002,740,0002,026,0007,010,0004,849,00011,893,00014,070,00016,572,00021,291,00019,825,00016,966,00021,674,00021,412,00021,053,00030,409,00027,080,00012,345,000
Dividend
Sep 26, 20240.77 GBP/sh
Earnings
Mar 11, 2025

Profile

Advanced Medical Solutions Group plc, together with its subsidiaries, designs, develops, manufactures, and distributes products for the wound care, surgical, and wound closure markets in the United Kingdom, Germany, France, rest of Europe, the United States, and internationally. It operates in two segments, Surgical and Woundcare. The Surgical segment offers topical tissue adhesives for wound closure and sealing under the LiquiBand brand; sutures and collagen-based products for the surgical and dental markets under the RESORBA brand; collagens; and laparoscopic device used to fix hernia meshes placed inside the body under the LiquiBand Fix8 brand, as well as internal sealants under the Seal-G/Seal-G MIST brand. The Woundcare segment provides wound care platform technologies, which include alginates, foams, films, fibres, hydrogels, antimicrobial dressings, and hydrocolloids, as well as wound care products under the ActivHeal brand. Advanced Medical Solutions Group plc was incorporated in 1991 and is headquartered in Winsford, the United Kingdom.
URL
https://www.admedsol.com/
IPO date
Apr 30, 2002
Employees
800
Domiciled in
GB
Incorporated in
GB

Valuation

Title
GBP in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
126,210
1.51%
124,330
14.48%
108,601
25.12%
Cost of revenue
108,259
109,036
94,780
Unusual Expense (Income)
NOPBT
17,951
15,294
13,821
NOPBT Margin
14.22%
12.30%
12.73%
Operating Taxes
5,268
5,026
4,122
Tax Rate
29.35%
32.86%
29.82%
NOPAT
12,683
10,268
9,699
Net income
15,889
-22.14%
20,406
16.73%
17,481
103.65%
Dividends
(4,775)
(4,341)
(3,845)
Dividend yield
Proceeds from repurchase of equity
(6,529)
263
721
BB yield
Debt
Debt current
1,164
1,059
1,153
Long-term debt
17,110
17,382
17,414
Deferred revenue
Other long-term liabilities
4,400
3,510
3,679
Net debt
(41,886)
(64,758)
(54,503)
Cash flow
Cash from operating activities
12,345
27,080
30,409
CAPEX
(3,544)
(9,964)
(6,463)
Cash from investing activities
(20,265)
(12,699)
(6,410)
Cash from financing activities
(13,256)
(5,704)
(4,405)
FCF
1,246
7,983
15,522
Balance
Cash
60,160
82,262
72,965
Long term investments
937
105
Excess cash
53,850
76,982
67,640
Stockholders' equity
212,075
199,520
175,845
Invested Capital
203,890
171,952
157,679
ROIC
6.75%
6.23%
5.99%
ROCE
6.68%
5.92%
5.94%
EV
Common stock shares outstanding
219,289
219,481
218,312
Price
Market cap
EV
EBITDA
28,739
24,138
22,669
EV/EBITDA
Interest
384
638
1,098
Interest/NOPBT
2.14%
4.17%
7.94%